About AGLE

Aeglea BioTherapeutics, Inc. (AGLE) is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat inborn errors of metabolism and cancer.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

AGLE is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 247.9 M 2.47865E+08 234 234 0.01% 0.000129635 68 K 67867
UBIO Proshares UltraPro Nasdaq Biotechnology 31.1 M 3.10775E+07 228 228 0.01% 7.481E-05 8 K 7613
URTY ProShares UltraPro Russell2000 105.8 M 1.05784E+08 2,016 2016 0.0% 1.81431E-05 6 K 5970
UWM ProShares Ultra Russell2000 184.1 M 1.84148E+08 2,016 2016 0.0% 2.69573E-05 11 K 10719
PZI Invesco Zacks Micro Cap ETF 16.7 M 1.67E+07 400 400 0.23% 0.00233 39 K 38780
VTWG Vanguard Russell 2000 Growth ETF 286.3 M 2.863E+08 1,245 1245 0.01% 0.00013 36 K 36125
VTWO Vanguard Russell 2000 ETF 1.6 B 1.6E+09 2,013 2013 0.01% 7E-05 106 K 105545
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.24908E+09 222 222 0.03% 0.0003 2.5 M 2450060
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.7 B 1.87292E+10 3,568 3568 0.0% 0 50 K 50440
IWC iShares Microcap ETF 916.2 M 9.16246E+08 1,452 1452 0.04% 0.0004 388 K 387503
IWM iShares Russell 2000 ETF 44.9 B 4.48577E+10 2,006 2006 0.01% 0.0001 2.8 M 2813120
IWO iShares Russell 2000 Growth ETF 9.3 B 9.28872E+09 1,239 1239 0.01% 0.0001 1.1 M 1144800
IWV iShares Russell 3000 ETF 9.7 B 9.71954E+09 2,931 2931 0.0% 0 73 K 73178

Wait, Before You Leave...